|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | The Effects of Dietary Fat and Calorie Density on Esophageal Acid Exposure and Reflux Symptoms显示文摘 | Mark Fox Carole Barr Suzanne Nolan Miranda Lomer Angela Anggiansah Terry Wong | 2007 | Clinical Gastroenterology and Hepatology2007，，4： | 2 |
| 2 | Software Reuse:Metrics and Models显示文摘 | Carol Terry | 1996 | ACM Computing Surveys1996，，6： | 1 |
| 3 | Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association显示文摘 | Michael Miller Neil J. Stone Christie Ballantyne Vera Bittner Michael H. Criqui Henry N. Ginsberg Anne Carol Goldberg William James Howard Marc S. Jacobson Penny M. Kris-Etherton Terry A. Lennie Moshe Levi Theodore Mazzone Subramanian Pennathur | 2011 | Circulation2011，，20： | 1 |
| 4 | Prediction and Control of ADA Software Defects 显示文摘 | TERRY COMPTON B CAROL WITHROW | 1990 | Journal of Systems andSoftware1990，12，3： | 1 |
| 5 | Trends in Waiting List Registration for Liver Transplantation for Viral Hepatitis in the United States显示文摘 | W. Ray Kim Norah A. Terrault Rachel A. Pedersen Terry M. Therneau Erick Edwards Andrew A. Hindman Carol L. Brosgart | 2009 | Gastroenterology2009，，5： | 1 |
| 6 | Intraocular lens implantation in the absence of capsular support显示文摘 | Michael D Wagoner Terry A Cox Reginald George Ariyasu Deborah S Jacobs Carol L Karp | 2003 | Ophthalmology2003，，4： | 1 |
| 7 | Upfront consolidation treatment with 131I-mIBG followed by myeloablative chemotherapy and hematopoietic stem cell transplantation in high-risk neuroblastoma显示文摘Importance:131I-metaiodobenzylguanidine(131I-mIBG)has a significant targeted antitumor effect for neuroblastoma.However,currently there is a paucity of data for the use of 131I-mIBG as a'front-line'therapeutic agent in those patients with newly diagnosed high-risk neuroblastoma as part of the conditioning regimen for myeloablative chemotherapy(MAC).Objective:To evaluate the feasibility of upfront consolidation treatment with 131I-mIBG plus MAC and hematopoietic stem cell transplantation(HSCT)in high-risk neuroblastoma patients.Methods:A retrospective,single-center study was conducted from 2003-2019 on newly diagnosed high-risk neuroblastoma patients without progressive disease(PD)after the completion of induction therapy.They received 131I-mIBG infusion and MAC followed by HSCT.Results:A total of 24 high-risk neuroblastoma patients were enrolled with a median age of 3.0 years at diagnosis.After receiving this sequential consolidation treatment,3 of 13 patients who were in partial response(PR)before 131I-mIBG treatment achieved either complete response(CR)(n=1)or very good partial response(VGPR)(n=2)after HSCT.With a median follow-up duration of 13.0 months after 131I-mIBG therapy,the 5-year event-free survival and overall survival rates estimated were 29%and 38%for the entire cohort,and 53%and 67%for the patients who were in CR/VGPR at the time of 131I-mIBG treatment.Interpretation:Upfront consolidation treatment with 131I-mIBG plus MAC and HSCT is feasible and tolerable in high-risk neuroblastoma patients,however the survival benefit of this 131I-mIBG regimen is only observed in the patients who were in CR/VGPR at the time of 131I-mIBG treatment. | Jianhua Feng Frankie WT Cheng Alex WK Leung Vincent Lee Eva WM Yeung Hoi Ching Lam Jeanny Cheung Grace KS Lam Terry TW Chow Carol LS Yan Chi Kong Li | 2020 | Pediatric Investigation2020，4，3： | 1 |
| 8 | The human Nramp2 gene:characterization of the gene structure,alternative splicing,promoter region and polymorphisms显示文摘 | Pauline L Lee Terri Gelbart Carol West | 1998 | Blood Cells Molecules and Disease1998，234，： | 1 |
| 9 | Trends in Waiting List Registration for Liver Transplantation for Viral Hepatitis in the United States显示文摘 | W. Ray Kim Norah A. Terrault Rachel A. Pedersen Terry M. Therneau Erick Edwards Andrew A. Hindman Carol L. Brosgart | 2009 | Gastroenterology2009，，5： | 1 |
| 10 | White matter injury in the premature infant:a comparison between serial cranial sonographic and MR findings at term显示文摘 | Terrie EI Nigel JA Carole S | 2003 | Am J Neuroradiol2003，24，： | 1 |
| 11 | 安全使用含浓缩钾药物的最佳实践显示文摘改善患者安全性的建议往往是在实践指南及很多专家或机构的建议基础上提出的, 但并未得到证实,尤其是那些有关如何使用含钾药品安全性方面的建议即使是目前已得到广泛认可的含钾溶液安全使用常规,也缺乏表示支持或否定的确凿证据或经验性证据当务之急是开展医疗卫生系统整体评估医疗保健系统的研究。 | Michelle Tubman Sumit R Majumdar Daniel Lee Carol Friesen Terry P Klassen 刘威(译) 张云鹏(译) 王琳(校) | 2006 | 英国医学杂志中文版2006，9，2： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员